MacroGenics Statistics Share Statistics MacroGenics has 63.09M
shares outstanding. The number of shares has increased by 0.59%
in one year.
Shares Outstanding 63.09M Shares Change (YoY) 0.59% Shares Change (QoQ) 0% Owned by Institutions (%) 83.6% Shares Floating 57.94M Failed to Deliver (FTD) Shares 20 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 4.08M, so 6.46% of the outstanding
shares have been sold short.
Short Interest 4.08M Short % of Shares Out 6.46% Short % of Float 7.95% Short Ratio (days to cover) 5.11
Valuation Ratios The PE ratio is -3.04 and the forward
PE ratio is -0.88.
MacroGenics's PEG ratio is
0.
PE Ratio -3.04 Forward PE -0.88 PS Ratio 1.37 Forward PS 1 PB Ratio 1.75 P/FCF Ratio -2.82 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for MacroGenics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.92,
with a Debt / Equity ratio of 0.32.
Current Ratio 3.92 Quick Ratio 3.92 Debt / Equity 0.32 Debt / EBITDA -0.65 Debt / FCF -0.52 Interest Coverage -99.17
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $435.01K Profits Per Employee $-196.38K Employee Count 341 Asset Turnover 0.57 Inventory Turnover n/a
Taxes Income Tax 944K Effective Tax Rate -1.43%
Stock Price Statistics The stock price has increased by -56.12% in the
last 52 weeks. The beta is 1.66, so MacroGenics's
price volatility has been higher than the market average.
Beta 1.66 52-Week Price Change -56.12% 50-Day Moving Average 1.51 200-Day Moving Average 2.34 Relative Strength Index (RSI) 48.06 Average Volume (20 Days) 1,239,527
Income Statement In the last 12 months, MacroGenics had revenue of 148.34M
and earned -66.97M
in profits. Earnings per share was -1.07.
Revenue 148.34M Gross Profit 136.04M Operating Income -110.58M Net Income -66.97M EBITDA -57.37M EBIT -64.91M Earnings Per Share (EPS) -1.07
Full Income Statement Balance Sheet The company has 182.84M in cash and 37.46M in
debt, giving a net cash position of 145.38M.
Cash & Cash Equivalents 182.84M Total Debt 37.46M Net Cash 145.38M Retained Earnings -1.17B Total Assets 224.56M Working Capital 126.65M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -68.37M
and capital expenditures -3.71M, giving a free cash flow of -72.08M.
Operating Cash Flow -68.37M Capital Expenditures -3.71M Free Cash Flow -72.08M FCF Per Share -1.15
Full Cash Flow Statement Margins Gross margin is 91.71%, with operating and profit margins of -74.54% and -45.14%.
Gross Margin 91.71% Operating Margin -74.54% Pretax Margin -44.51% Profit Margin -45.14% EBITDA Margin -38.67% EBIT Margin -74.54% FCF Margin -48.59%
